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Abstract
Background: Type 2 diabetes mellitus is a chronic metabolic disorder that is associated with mortality and morbidity.
Recently, several plant-based agents have been used in the management of diabetes. Pluchea indica has been traditionally
consumed as a medicinal plant in Southeast Asia, and its leaves have demonstrated induction of hypoglycemic effect in
normal rats. This in vitro study aimed to evaluate the potency of P. indica extracts in stimulating glucose consumption in
human liver CCL-13 cell line model. Methods: P. indica leaves were dried and extracted using a series of organic solvents
and water. The effect of the extracts on cell viability was determined by MTT assay. The glucose consumption was
analyzed using glucose oxidase method. Results: Our results revealed that the methanol extract of P. indica could
significantly increase glucose consumption of cells in a concentration-dependent manner, which suggests the usefulness
of the extract as an antidiabetic candidate via stimulation of glucose uptake into the liver cells. Conclusion: Our study
suggests that P. indica is a potential natural candidate for diabetes mellitus management.
Keywords: diabetes mellitus type 2, liver, cell line, glucose oxidase, Pluchea indica

the importance of identifying novel antidiabetic drugs with
minimum side effects.

Introduction
Diabetes mellitus is a chronic disease that is characterized
by persistent hyperglycemia with disturbances in
carbohydrate, fat, and protein metabolisms resulting from
the defects in insulin secretion or insulin action or a
combination of both the factors.1 The worldwide figure
of people with diabetes in the year 2015 indicated that
415 million people had the disease and the number was
estimated rise to 642 million by 2040.2 Over 90% of the
global cases account for type 2 diabetes. Modernized and
sedentary lifestyles have led to over-nutrition and lack of
physical exercises, thereby increasing the prevalence of
obesity as a known risk factor for the development of
type 2 diabetes.3,4 Type 2 diabetes is primarily managed
by controlling blood glucose levels and practicing a
healthy lifestyle.5 A number of medications with varying
mechanisms of action are commonly prescribed to control
the blood glucose levels i.e. α-glucosidase inhibitors,
insulin secretagogues, biguanides, thiazolidinedione, and
insulin mimetic agents. However, these drugs may cause
various adverse effects, such as gastro-intestinal
complaints and hypoglycemia.6 These reasons highlight

Plant-derived natural products have been playing an
important role in improving the human health.7 Pluchea
indica (L.) Less (Compositae) is found abundantly in the
tropical coasts of the South and Southeast Asian regions.
The roots and leaves are reported to possess antiinflammatory8, antimicrobial7, hepatoprotective, antiulcer9,
and wound healing properties.10 Two independent in vivo
studies using rat models demonstrated the antihyperglycemic effect of P. indica in streptozotocininduced diabetic rats. Moreover, P. indica also
significantly induced hypoglycemic effect in normal
rats.11,12 A study on 3T3-L1 adipocyte cells revealed that
P. indica may play a role in the control adipogenesis of
3T3-L1 cells by decreasing lipid accumulation and
inhibiting adipogenesis.13 However, no attempt has yet
been made to explore the antidiabetic property of P.
indica using liver cell model. Investigating the effect of
new drug candidates on hepatic glucose metabolism is
essential because the liver is the main organ for
controlling blood glucose.14 This in vitro research was
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designed to explore the effect of P. indica extracts on
glucose consumption in human liver CCL-13 cell line.

Methods
Plant material and extract preparation. The leaves of
P. indica were collected in August 2010 from the coastal
areas in Kuantan, Pahang state, Malaysia. The plant was
identified by Dr. Shamsul Khamis from the University
Putra Malaysia. A voucher specimen of P. indica (no.
MT-11-12) was deposited at the Herbarium, Kulliyyah of
Pharmacy, International Islamic University Malaysia.
The P. indica leaves were dried and ground into powder
(294 g) before subjecting them to a serial extraction of
organic solvents in the sequence of n-hexane,
dichloromethane, ethyl acetate, and methanol. The
extraction was performed using a Soxhlet apparatus at
room temperature and concentrated in a rotary evaporator
at 55 C. A different sample of P. indica powdered leaves
(25 g) was extracted using distilled water and freezedried to yield a dried extract. The total yield (w/w) of the
extracts included n-hexane (4.16%), dichloromethane
(1.45%), ethyl acetate (4.96%), methanol (14.13%), and
water (15.01%). The extracts were stored in airtight glass
containers at 4 C.
Cell growth and treatment. The liver cell line was
purchased from American Type Culture Collection No.
CCL-13 (USA). All the reagents for cell culture and
maintenance were from Invitrogen (USA). The cells were
grown in DMEM supplemented with 10% fetal bovine
serum, 100 U/mL penicillin, and 0.1 mg/mL
streptomycin at 37 C under an atmosphere of 95% air
and 5% CO2.
Cell viability assay. Different concentrations of extracts
or 0.2% ethanol (as a control vehicle) were prepared as
working solutions in cell growth medium DMEM for 48h
of treatment. The cells (2 × 105 cells/mL) were plated in
100 mL of medium/well of a 96-well plate. Cell viability
was determined by adding 20 µL of 5 mg/mL MTT 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (Invitrogen, USA) and further incubated at 37 °C
for 3 h. The supernatant was removed, and 100 μL DMSO
was added to each well for 1 h. The absorbance was
measured in a spectrophotometer at 570 nm (reference:
630 nm). All experiments were repeated three times in
triplicates.
Glucose oxidase assay. The glucose concentration was
determined by both the activities of glucose oxidase and
horseradish peroxidase. Glucose (GO) Assay Kit (Code
GAGO-20) was purchased from Sigma (USA). The cells
were seeded in a 96-well plate at a density of 2 × 105
cells/mL. Glucose consumption was measured after a 24
h incubation with samples at concentrations of 0.2, 0.1,
and 0.05 mg/mL, respectively. Cellular glucose uptake
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was assayed in 10 L of medium using glucose oxidase
method as prescribed in the manufacture protocols prior
to absorbance measurement in a spectrophotometer. The
color intensity of the reaction product at 540 nm was
found to be proportional to the original glucose
concentration in the sample. The standard glucose curve
was prepared according to the previous study.15 The
amount of glucose in the wells (i.e., the quantity of
glucose consumed by the cells) was calculated by
subtracting the glucose concentration in cell-plated wells
from those of blank wells.16
Statistical analysis. The data were representative of at
least triplicate experiments and analyzed by comparing
experimental samples of the same treatment conditions as
a group with negative control (untreated) samples using
one-way ANOVA, followed by evaluation by Dunnett's
post-hoc test. The results were reported as the mean
(standard error of means). The statistic significant
considered as p < 0.05.

Results
The phytochemical screening of the crude extracts (i.e.,
n-hexane, dichloromethane, ethyl acetate, and methanol)
revealed the presence of carbohydrates, saponins, sterol/
terpenes, phenol, and flavonoids, as shown in Table 1.
Next, various concentrations of the P. indica extracts
were exposed on the cells for 48 h and then measured by
MTT assay to determine the maximum concentration of
the extracts that could be tolerated without causing
toxicity (Figure 1). The results demonstrated that the
concentrations selected for the study (0.05, 0.1, and 0.2
mg/mL) did not impair cell viability during the period of
incubation.
Finally, the glucose oxidase assay was performed to
examine the glucose uptake activity of the extracts. As
shown in Figure 2, the methanol extracts significantly
elevated glucose consumption in a concentrationdependent manner, whereas the level of glucose uptake
induced by other extracts remained unchanged.

Discussion
The liver plays a vital role in regulating glucose
homeostasis.17 In response to ingestion of glucose or a
mixed meal, glucose enters hepatocytes via the glucose
transporter GLUT2 and is used to synthesize glycogen.
In the fasting state, the liver sustained the level of blood
glucose through glycogenolysis and gluconeogenesis,
which subsequently released the glucose into the blood
circulation.18,19 Controlling hepatic glucose metabolism
has been considered as a strategy in the development of
antidiabetic drugs. For instance, metformin has been
widely used to reduce the hepatic glucose output in
April 2019 | Vol. 23 | No. 1
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treating type 2 diabetes mellitus.20 Other liver-targeted
antidiabetic candidates, such as activators of glucokinase,
inhibitors of fructose 1,6-bisphosphatase, inhibitors of
glycogen phosphorylase, and antagonists of the glucagon
receptor are currently being studied in different phases of

clinical trials.21 However, so far, none of them have
received approval. Hence, the potential to specifically
target hepatic glucose homeostasis still remains to be
exploited.

Table 1. Qualitative analysis of the phytochemicals of P. indica extracts

Extracts
n-hexane
dichloromethane
ethyl acetate
methanol
−
−
−
−
N.T.
N.T.
N.T.
+
N.T.
N.T.
N.T.
+
N.T.
N.T.
N.T.
+
N.T.
N.T.
N.T.
−
+
−
−
−
+
+
+
−
−
−
+
+
−
−
−
+
Key: + presences of constituent; − absence of constituents; N.T. not tested

Detection
Alkaloids
Carbohydrate
Glycosides
Saponin
Amino acids
Terpene
Steroids
Phenolics
Flavonoids

water
−
+
+
+
−
−
−
+
+

160

Cell Viability (%)

140
120
100

0.05 mg/mL

80

0.1 mg/mL

60

0.2 mg/mL

40
20
0
n-hexane

dichloromthane

ethylacetate

methanol

aqueous

control (vehicle)

Figure 1. The CCL-13 cell viability after 48 h of exposure using different concentrations of extracts (0.05, 0.1, and 0.2 mg/mL) were
analyzed by MTT assay. Data were presented as means ± SE of three replicates and expressed as percentages of the control value.

0.006

Glucose Concentration (mg/mL)

0.005

0.004

0.05 mg/mL
0.1 mg/mL

0.003
0.2 mg/mL
0.002

0.001

n-hexane

dichloromthane

ethylacetate

methanol

aqueous

control (vehicle)

Figure 2. The methanol extracts of P. indica enhanced the glucose consumption in CCL-13 cells in a concentration-dependent manner.
The glucose consumption of methanol extracts at the concentrations of 0.05, 0.1, and 0.2 mg/mL displayed significant difference at p
< 0.05 for all samples groups. The mean score for the methanol-treated cells (0.05, 0.1, and 0.2 mg/mL) was significantly different
from that of the control group.
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Clinical trial of new drugs can be only started after
multiple rounds of pre-clinical experiments, involving
tests on animal and cell culture, have been conducted.
Hepatic glucose metabolism has been extensively studied
both in vivo and in vitro. Primary human liver cells
(hepatocytes) have been reported as the best in vitro
model; however, their supplies are quite limited.22 Hence,
several other cell lines derived from the liver such as
IHH, HepaRG, HepG2, and Huh-7 have been utilized as
a model. In the present study, we utilized the human
CCL-13 liver cell line as an in vitro model to demonstrate
the glucose uptake induced by plant medicine P. indica.
The glucose uptake activity was analyzed using a
chromogenic glucose oxidase method, which was chosen
due to its reliability, convenient, and economical for bulk
screening of new drug candidates.15
The crude extracts of P. indica were prepared by
sequential extraction methods. We identified that the
polar compounds were more abundant than non-polar
ones in which both methanolic and aqueous extracts
exhibited highest yields. The qualitative screening
revealed that the polar compounds contain phenolic and
flavonoid substances. Similar studies reported that the
methanolic extract23 and ethanol extract24 of P. indica
leaves had the highest phenolic compound than the other
parts of plants. The potential of phenolic compounds of
plant origin have also been considered in the
management of oxidative stress-linked chronic diseases,
such as diabetes and hepatic glucose homeostasis.25 In
agreement with this, our findings revealed that methanol
extracts of P. indica induced the uptake of glucose by the
CCL-13 cells. We postulate that the phenolic compound
in the methanolic extract of P. indica may be responsible
for promoting glucose consumption in the CCL-13 cell
line. The result is supported by previous in vitro study
using glucose oxidase method in HepG2 cell line, which
demonstrated that phenolic compounds had significant
glucose lowering activity.26 We also detected the
presence of phenolic substances in the aqueous and ethyl
acetate extracts; however, no significant increase of
glucose uptake was observed. We speculate that the
proportion and the type of phenolic compounds in the
extracts might influence the results. Further studies are
warranted to identify the bioactive compound(s)
responsible for the induction of glucose uptake and
elucidate the antidiabetic mechanisms of P. indica on
different cell lines as well as in an in vivo model.
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